> top > docs > PMC:7205724 > spans > 486-640 > annotations

PMC:7205724 / 486-640 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
11 13-21 Disease denotes COVID-19 MESH:C000657245
17 47-50 Gene denotes IL6 Gene:3569
18 106-109 Gene denotes IL6 Gene:3569
19 74-82 Species denotes patients Tax:9606
20 26-37 Chemical denotes Tocilizumab MESH:C502936
21 88-96 Disease denotes COVID-19 MESH:C000657245
53 125-142 Species denotes novel coronavirus Tax:2697049
54 144-153 Species denotes SARS-CoV2 Tax:2697049

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 13-21 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 88-96 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 144-148 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T4 13-21 Species denotes COVID-19 NCBItxid:2697049
T5 88-96 Species denotes COVID-19 NCBItxid:2697049
T6 144-153 Species denotes SARS-CoV2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T9 23-110 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 112-120 Sentence denotes Abstract

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
11 13-21 Disease denotes COVID-19 MESH:C000657245
20 26-37 Chemical denotes Tocilizumab MESH:C502936
17 47-50 Gene denotes IL6 Gene:3569
19 74-82 Species denotes patients Tax:9606
21 88-96 Disease denotes COVID-19 MESH:C000657245
18 106-109 Gene denotes IL6 Gene:3569
53 125-142 Species denotes novel coronavirus Tax:2697049
54 144-153 Species denotes SARS-CoV2 Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T45 47-50 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T89 106-109 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T72 0-9 NN denotes prognosis
T73 10-12 IN denotes of
T74 13-21 NN denotes COVID-19
T75 23-24 IN denotes •
T76 26-37 NNP denotes Tocilizumab
T77 37-38 -COMMA- denotes ,
T78 39-41 DT denotes an
T79 42-50 NN denotes anti-IL6
T80 50-51 -COMMA- denotes ,
T81 52-55 MD denotes can
T82 56-62 VB denotes confer
T83 63-70 NN denotes benefit
T84 71-73 IN denotes in
T85 74-82 NNS denotes patients
T86 83-87 IN denotes with
T87 88-96 NN denotes COVID-19
T88 97-100 CC denotes and
T89 101-105 JJ denotes high
T90 106-109 NN denotes IL6
T91 112-120 NN denotes Abstract
T92 121-124 DT denotes The
T93 125-130 JJ denotes novel
T94 131-142 NN denotes coronavirus
T95 142-143 -COMMA- denotes ,
T96 144-153 NN denotes SARS-CoV2
T97 153-154 -COMMA- denotes ,
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in
R80 T85 T86 arg1Of patients,with
R81 T88 T86 arg2Of and,with
R82 T87 T88 arg1Of COVID-19,and
R83 T90 T88 arg2Of IL6,and
R84 T90 T89 arg1Of IL6,high
R85 T94 T92 arg1Of coronavirus,The
R86 T94 T93 arg1Of coronavirus,novel
R87 T94 T95 arg1Of coronavirus,","
R88 T96 T95 arg2Of SARS-CoV2,","

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 13-21 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 88-96 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 144-153 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T9 23-110 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 112-120 Sentence denotes Abstract